Disease prevalence, and survey weighted, age, gender and ethnicity adjusted model estimates (odds ratios with 95% confidence intervals) of associations with per standard deviation increases of Bisphenol A concentration with adjustment for urinary creatinine: adults aged 18 to 74.

<p>Disease prevalence, and survey weighted, age, gender and ethnicity adjusted model estimates (odds ratios with 95% confidence intervals) of associations with per standard deviation increases of Bisphenol A concentration with adjustment for urinary creatinine: adults aged 18 to 74.</p

Distribution of Bisphenol A concentration (ng/ml) in NHANES 2003/04 and 2005/06.

<p>Note: Boxes represent upper and lower quartiles with median line, whiskers end at 5^th percentile (below LLOD) and 95^th percentile of distribution. Data from adults aged 18 to 74 years.</p

Fully adjusted^* survey weighted model estimates^† (with 95% confidence intervals) of logged liver enzyme analyte associations per standard deviation increase of Bisphenol A, with adjustment for urinary creatinine: adults aged 18 to 74.

*<p>models adjusted for age, gender, ethnicity, education, income, BMI, waist circumference, smoking status and urinary creatinine.</p>†<p>Coefficients represent change in logged analyte level for each standard deviation change in bisphenol A.</p

Sample characteristics by NHANES wave.

*<p><b>Note: estimate based on survey weighted age, sex ethnicity adjusted logistic models in adults aged 18–74 years with valid BPA measures, comparing NHANES wave.</b></p

Fully adjusted^* survey weighted model estimates (odds ratios with 95% confidence intervals) of disease associations per standard deviation increase of Bisphenol A concentration: adults aged 18 to 74.

*<p>models adjusted for age, gender, ethnicity, education, income, BMI, waist circumference, smoking status and urinary creatinine.</p

Demographics of the pooled dataset and the weighted mean urinary tungsten concentration for the various demographic variables.

<p><i>P</i> values represent statistical significance of the different tungsten concentrations for each demographic variable. The <i>P</i> value presented in () includes an adjustment for urinary creatinine. Statistical comparisons excluded individuals in the unknown categoriesTables.</p

Odds Ratios and 95% confidence intervals representing the odds of a stroke diagnosis per 1 unit increase in log transformed urinary tungsten (expressed as µg per mg of urinary creatinine) for NHANES participants less than 75 years of age or less than 50 years of age.

a<p>The adjusted models include age, sex, ethnicity, SES, smoking, occupation, BMI, hypertenstion, hypercholesterolemia, molybdenum and cobalt concentration as covariates.</p>b<p>In this model all urinary tungsten measures were included, including the 503 individuals with a concentration below the lowest detectable limit.</p><p>Statistical significance is denoted by ^?, * and ** representing <i>P</i><0.1, <i>P</i><0.05 and <i>P</i><0.01 respectively.</p

Bar charts representing the mean urinary tungsten concentrations in individuals with and without a self-reported stroke or CVD diagnosis.

<p>Error bars represent the 95% confidence intervals and the <i>P</i> value represents the comparison of tungsten concentrations in people with and without a stroke diagnosis.</p

Odds Ratios and 95% confidence intervals representing the odds of a CVD diagnosis per 1 unit increase in log transformed urinary tungsten (expressed as µg per mg of urinary creatinine) for NHANES participants less than 75 years of age or less than 50 years of age.

a<p>The adjusted models include age, sex, ethnicity, SES, smoking, alcohol consumption, occupation, BMI, hypertenstion, hypercholesterolemia, molybdenum and cobalt concentration as covariates.</p>b<p>In this model all urinary tungsten measures were included, including the 503 individuals with a concentration below the lowest detectable limit.</p><p>Statistical significance is denoted by * representing <i>P</i><0.05.</p

Odds ratios per SD increase in uBPA (5.96 ng/ml) of diagnosed coronary artery features comparing age and sex adjusted models, fully adjusted models and fully adjusted models where the severity of disease is further broken down to show 1, 2, and 3 vessel disease (VD).

<p>Note: full adjustment included age, sex, BMI category, occupational social class and diabetes status.</p